Top Markets
#1 Nesa Nesa +799.79%
#2 Cortex Cortex +69.18%
#3 Merlin's Seal BTC Merlin's Seal BTC +45.83%
#4 QuantixAI QuantixAI +24.59%
#5 EXOD EXOD +22.78%
#6 Instadapp Instadapp +22.31%
#7 Pons Pons +21.22%
#8 Cash Cat Cash Cat +12.96%
#9 PondCoin PondCoin +12.14%
#10 Fartcoin Fartcoin +11.45%
Coin of the day
Nesa Nesa
設定
言語
日本
通貨
USD
テーマ
Definium Therapeutics, Inc. Definium Therapeutics, Inc.

Definium Therapeutics, Inc.

DFTX
株式のランク #3212
Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm... Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another significant compound, MM402 – an R-enantiomer of 3,4-methylenedioxymethamphetamine – is in Phase 1 trials, targeting the fundamental symptoms of autism spectrum disorder. The company maintains its headquarters in New York, New York.
株価
$44.42
最終同期: 2026-08-25
時価総額
$5.90B
変化（1日）
2.66%
変化（1年）
344.66%
国
US
取引 Definium Therapeutics, Inc. (DFTX)

カテゴリー

Healthcare
Definium Therapeutics, Inc.（DFTX）のEPS
2026 時点のEPS TTM: 0
Definium Therapeutics, Inc.の最新の財務報告と株価によると、同社の現在のEPS（TTM）は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Definium Therapeutics, Inc.のEPS履歴（2026から2026まで）
各年末時点のEPS
年 EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS
企業 EPS EPSの差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH